You searched for metabolic diseases - Page 5 of 64

In Depth 7 Apr 2025

Will tRNA therapy be the next big thing in genetic disease treatment?

…genetic diseases But how exactly does tRNA play a role in treating diseases? Since their initial description in 1958, tRNAs have largely been viewed as intermediaries in the translation of…

April 7, 2025 - 12 minutesmins - By Willow Shah-Neville

News and Trends 1 Jun 2023

Fighting obesity with gene therapy

…apply the ex vivo gene therapy technique to generate and implant cells that express the CPT1AM protein, an enzyme that plays a decisive role in many metabolic diseases such as…

June 1, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 10 Oct 2024

12 biotech unicorns revolutionizing the future of healthcare

…metabolic dysfunction-associated steatotic liver disease (MASLD), based on targets identified by insitro using its AI-based platform. In addition to metabolic diseases, the biotech unicorn is also working in neurodegeneration and…

October 10, 2024 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 21 Dec 2023

Five companies racing to bring their NASH treatments toward the finish line

…in San Francisco, 89bio is on a mission to develop and deliver innovative therapies to treat patients with liver and cardiometabolic diseases. Its lead candidate is called pegozafermin, and is…

December 21, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 22 Jan 2019

No Guts, No Glory: How Microbiome Research is Changing Medicine

…metabolic indications,” Isabelle de Cremoux, CEO of Seventure, told me. “Then we saw innovations applied to the field of autoimmune and immune diseases. Then skincare popped up and more recently…

January 22, 2019 - 10 minutesmins - By Clara Rodríguez Fernández

Opinion 26 Apr 2023

Can mRNA vaccines tackle multiple diseases?

…vaccines to protect people of all ages from diseases and deliver immunization. Although vaccination is one of the most effective public health interventions to prevent, control and even eradicate diseases,…

April 26, 2023 - 9 minutesmins - By External Contributor

Best in Biotech 2 May 2024

Eight monoclonal antibody biotechs making strides in the clinic

…company Regeneron also has over 25 monoclonal antibodies in various stages of clinical development to address conditions ranging from anemia and metabolic diseases to cancer, inflammatory diseases, and rare diseases….

May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter

More News! 26 Jul 2024

Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies

…strategic choice to focus its pipeline on endocrine and metabolic diseases. “Rare endocrine diseases can be an opportunity for Confo to go into late-stage development and even commercialization, while big…

July 26, 2024 - 8 minutesmins - By Jules Adam

Podcast 8 Dec 2023

Can worms provide treatments for some diseases?

U.S. company Holoclara is looking to tackle diseases through the development of worm-derived therapeutics. Allergic and autoimmune diseases were first described in the early 1900s, which Holoclara said is the…

December 8, 2023 - 4 minutesmins - By Jim Cornall

In Depth 27 Jun 2023

The promise of immunotherapy for autoimmune diseases

…on healthy cells and tissues? For the millions of people battling autoimmune diseases, this can severely affect their lives. However, advances in immunotherapy have revolutionized how these autoimmune diseases are…

June 27, 2023 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 2 Jan 2025

A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development

…known for its focus on infectious diseases, lung diseases, and cancer, also seems to be willing to spread its wings across new indications. The company has now forged a partnership…

January 2, 2025 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 14 Dec 2015

Red Blood Cells to Carry Drugs? A US Start-Up Inspired by French Biotech to Focus on Rare Metabolic Disease

…through Flagship’s VentureLabs to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases. Erytech in Lyon (France) have already developed a…

December 14, 2015 - 3 minutesmins - By Dani Bancroft

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Will tRNA therapy be the next big thing in genetic disease treatment?

Fighting obesity with gene therapy

12 biotech unicorns revolutionizing the future of healthcare

Five companies racing to bring their NASH treatments toward the finish line

No Guts, No Glory: How Microbiome Research is Changing Medicine

Can mRNA vaccines tackle multiple diseases?

Eight monoclonal antibody biotechs making strides in the clinic

Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies

Can worms provide treatments for some diseases?

The promise of immunotherapy for autoimmune diseases

A surge in deals: GSK bets on ADC, neuro and fibrotic diseases to bolster drug development

Red Blood Cells to Carry Drugs? A US Start-Up Inspired by French Biotech to Focus on Rare Metabolic Disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!